hCDC4 variation in osteosarcoma

详细信息    查看全文

• 作者：Taiqiang Yan ; Jay S. Wunder ; Nalan Gokgoz ; Kelly K.Y. Seto ; Robert S. Bell and Irene L. Andrulis
• 刊名：Cancer Genetics and Cytogenetics
• 出版年：2006
• 出版时间：September 2006
• 年：2006
• 卷：169
• 期：2
• 页码：138-142
• 全文大小：140 K

文摘

The hCDC4 gene (also known as Fbw7 or Archipelago) encodes an F-box protein that is responsible for targeting cyclin E for Skp1-cullin-F box protein (SCF) ubiquitination and proteosomal degradation. Disruption of this pathway has been associated with chromosomal instability and aneuploidy in several cancer cell lines and primary tumors. This study aimed to examine whether hCDC4 mutations contribute to aneuploidy in osteosarcoma. We analyzed 147 primary high-grade osteosarcoma specimens and 6 osteosarcoma cell lines. The protein truncation test (PTT) and single-strand conformation polymorphism (SSCP) analysis with subsequent sequencing were performed to detect alterations of the hCDC4 gene. All specimens exhibited the same PTT pattern of normal bands with less intense common bands. Two shifts were detected by SSCP, and subsequent DNA analysis identified one in-frame three-base GAG (424-426) deletion and one silent nucleotide substitution (C1261T). We conclude that somatic hCDC4 mutations are infrequent in osteosarcoma, and are unlikely to play an important role in aneuploidy of this tumor.